Icecure Medical Financials

ICCM Stock  USD 0.83  0.04  5.06%   
Based on the analysis of Icecure Medical's profitability, liquidity, and operating efficiency, Icecure Medical may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Icecure Medical's Common Stock is very stable compared to the past year. As of the 27th of November 2024, Net Invested Capital is likely to grow to about 16.3 M, while Other Current Liabilities is likely to drop about 1.8 M. Key indicators impacting Icecure Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio4.953.6642
Significantly Up
Pretty Stable
The financial analysis of Icecure Medical is a critical element in measuring its lifeblood. Investors should not minimize Icecure Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(13.92 Million)

  
Understanding current and past Icecure Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Icecure Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Icecure Medical's assets may result in an increase in income on the income statement.

Icecure Medical Stock Summary

Icecure Medical competes with BrainsWay, SurModics, STRATA Skin, Tenon Medical, and Brainsway. IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation of tumors in the human body. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Icecure Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINIL0011224156
CUSIPM53071136
LocationIsrael
Business Address7 HaEshel Street,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.icecure-medical.com
Phone972 4 623 0333
CurrencyUSD - US Dollar

Icecure Medical Key Financial Ratios

Icecure Medical Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets7.3M10.3M32.3M30.2M16.4M12.7M
Other Current Liab1.1M3.1M2.0M2.8M3.0M1.8M
Net Debt(5.5M)(3.2M)(24.7M)(23.1M)(9.9M)(10.4M)
Retained Earnings(48.5M)(57.0M)(58.4M)(75.4M)(90.1M)(85.6M)
Accounts Payable425.7K645K881K714K502K452.6K
Cash5.8M3.5M25.6M23.7M10.5M9.3M
Net Receivables104.8K165K771K366K103K108.2K
Inventory717.3K1.1M2.0M2.9M2.3M1.2M
Other Current Assets301.1K5.0M2.0M1.2M965K1.4M
Total Liab4.7M5.8M5.3M4.8M4.2M3.6M
Total Current Assets6.9M9.7M30.3M28.1M14.2M11.8M
Common Stock1.3M2.7M3.5M5.0M5.8M6.1M
Other Assets139K118K333K34K39.1K37.1K
Other Liab2.7M3.3M5.7M618K556.2K528.4K
Net Tangible Assets9.1M14.7M27.0M25.4M29.2M16.1M
Net Invested Capital9.1M14.7M27.0M25.4M12.2M16.3M
Net Working Capital11.3M18.6M26.3M23.8M10.3M16.7M

Icecure Medical Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense22.8K31.7K171K239K215.1K120.2K
Total Revenue1.7M4.1M4.1M3.1M3.2M2.1M
Gross Profit576.4K2.7M2.2M1.4M1.3M957.4K
Operating Income(4.6M)(4.4M)(9.7M)(16.7M)(15.6M)(14.8M)
Ebit(4.6M)(4.1M)(9.7M)(16.7M)(15.6M)(14.8M)
Research Development2.8M4.1M5.9M9.1M8.3M8.7M
Ebitda(4.6M)(4.1M)(9.6M)(16.5M)(15.3M)(14.5M)
Cost Of Revenue1.1M1.4M1.9M1.6M1.9M1.1M
Income Before Tax(4.8M)(4.7M)(9.9M)(17.0M)(14.7M)(13.9M)
Net Income(4.8M)(4.8M)(10.1M)(17.2M)(14.7M)(13.9M)
Income Tax Expense(13.6K)86.8K171K239K155.1K162.9K
Net Interest Income(698K)(880K)(171K)(239K)924K970.2K

Icecure Medical Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(6.9K)(369.8K)(891K)(902K)582K611.1K
Change In Cash1.2M(2.7M)22.1M(2.0M)(13.1M)(12.5M)
Free Cash Flow(1.8M)(4.0M)(13.1M)(15.2M)(13.0M)(12.4M)
Depreciation155.4K266.2K127K248K323K339.2K
Other Non Cash Items(59.5K)310.1K5K359K(25K)(23.8K)
Capital Expenditures102.2K237.9K533K891K480K246.6K
Net Income(4.8M)(4.7M)(9.9M)(17.0M)(14.7M)(13.9M)
End Period Cash Flow5.8M3.5M25.6M23.7M10.5M9.0M
Change To Netincome1.4M1.1M1.8M321K288.9K274.5K

Icecure Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Icecure Medical's current stock value. Our valuation model uses many indicators to compare Icecure Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Icecure Medical competition to find correlations between indicators driving Icecure Medical's intrinsic value. More Info.
Icecure Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Icecure Medical's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Icecure Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Icecure Medical Systematic Risk

Icecure Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Icecure Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Icecure Medical correlated with the market. If Beta is less than 0 Icecure Medical generally moves in the opposite direction as compared to the market. If Icecure Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Icecure Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Icecure Medical is generally in the same direction as the market. If Beta > 1 Icecure Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Icecure Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Icecure Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Icecure Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0992

At this time, Icecure Medical's Price Earnings To Growth Ratio is very stable compared to the past year.

Icecure Medical November 27, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Icecure Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Icecure Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Icecure Medical based on widely used predictive technical indicators. In general, we focus on analyzing Icecure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Icecure Medical's daily price indicators and compare them against related drivers.
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.29)
Revenue Per Share
0.071
Quarterly Revenue Growth
0.079
Return On Assets
(0.47)
Return On Equity
(0.94)
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.